Published in Mol Endocrinol on September 01, 1988
Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest (1989) 0.97
Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. BMC Cancer (2006) 0.96
Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene. Biochem J (1994) 0.87
JAK-STAT1/3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats. Mol Pain (2012) 0.81
Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment. Diabetes Metab Syndr Obes (2010) 0.80
Increased expression of proopiomelanocortin (POMC) mRNA in adrenal glands of mice undergoing graft-versus-host disease (GVHD): association with persistent elevated plasma corticosterone levels. Clin Exp Immunol (1995) 0.77
Normal and abnormal regulation of beta-msh in man. J Clin Invest (1969) 2.68
Radioimmunoassay of beta-MSH in human plasma and tissues. J Clin Invest (1967) 2.44
Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J Clin Invest (1983) 2.24
Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res (1969) 2.16
The ectopic ACTH syndrome. Cancer Res (1965) 1.97
Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry (1999) 1.96
The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res (1996) 1.94
Epidermal growth factor: effects of androgens and adrenergic agents. Endocrinology (1974) 1.87
Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab (1991) 1.82
Results of treatment in 108 patients with Cushing's syndrome. N Engl J Med (1971) 1.69
Radioimmunoassay of epidermal growth factor. Endocrinology (1972) 1.62
Isolated ACTH deficiency: a heterogeneous disorder. Critical review and report of four new cases. Medicine (Baltimore) (1982) 1.61
Light synchronization of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. J Clin Endocrinol Metab (1969) 1.54
Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med (1981) 1.46
The Cushing syndrome: quest for the Holy Grail. Ann Intern Med (1994) 1.38
Adenosine 3',5'-monophosphate (cyclic AMP) as the mediator of the actions of melanocyte stimulating hormone (MSH) and norepinephrine on the frog skin. Endocrinology (1969) 1.29
Diurnal rhythm and disappearance half-time of endogenous plasma immunoreactive beta-MSH (LPH) and ACTH in man. J Clin Endocrinol Metab (1978) 1.27
Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues. J Histochem Cytochem (1985) 1.22
Epidermal growth factor (urogastrone) in human fluids: size heterogeneity. J Clin Endocrinol Metab (1979) 1.21
Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab (1973) 1.20
Epidermal growth factor: identification of a new hormone in human urine. Science (1975) 1.20
Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. J Clin Endocrinol Metab (1971) 1.18
Results of treating childhood Cushing's disease with pituitary irradiation. N Engl J Med (1977) 1.17
Biologic and immunologic characterization and physical separation of ACTH and ACTH fragments in the ectopic ACTH syndrome. J Clin Invest (1973) 1.17
Specific demonstration of the human hypophyseal adrenocortico-melanotropic (ACTH-MSH) cell. J Clin Endocrinol Metab (1974) 1.17
Homologous radioimmunoassay for human epidermal growth factor (urogastrone). J Clin Endocrinol Metab (1978) 1.17
Corticotropin, lipotropin, and beta-endorphin production by a human nonpituitary tumor in culture: evidence for a common precursor. Proc Natl Acad Sci U S A (1978) 1.16
ACTH antibodies in patients receiving depot porcine ACTH to hasten recovery from pituitary-adrenal suppression. J Clin Invest (1967) 1.16
Studies of ACTH antibodies and their reactions with inactive analogues of ACTH. Endocrinology (1966) 1.15
Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem (1984) 1.15
Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest (1983) 1.14
A method of preparing adrenal cell suspensions and its applicability to the in vitro study of adrenal metabolism. Endocrinology (1968) 1.13
ACTH and MSH production by a single cloned mouse pituitary tumor cell line. Endocrinology (1973) 1.11
Cowden disease: gene marker studies and measurements of epidermal growth factor. Am J Hum Genet (1986) 1.10
Radioimmunologic evidence for alpha-MSH (melanocyte stimulating hormone) in human pituitary and tumor tissues. J Clin Endocrinol Metab (1967) 1.10
Differences between ectopic MSH and pituitary MSH. J Clin Endocrinol Metab (1971) 1.06
Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color. Endocrinology (1969) 1.06
The nature of the immunoreactive lipotropins in human plasma and tissue extracts. J Clin Invest (1978) 1.05
Psychiatric phenomenology in Cushing's disease. Pharmacopsychiatry (1992) 1.04
Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor. J Clin Endocrinol Metab (1978) 1.04
Epidermal growth factor (urogastrone) in human tissues. J Clin Endocrinol Metab (1979) 1.04
Comparative effects of angiotensin and ACTH on cyclic AMP and steroidogenesis in isolated bovine adrenal cells. J Clin Invest (1973) 1.04
Radioimmunoassay of human epidermal growth factor (urogastrone). J Clin Endocrinol Metab (1977) 1.03
Inhibition of adrenocorticotropic hormone production by glucocorticoids in mouse pituitary tumor cells. Endocrinology (1973) 1.03
Plasma concentrations of immunoreactive human epidermal growth factor (urogastrone) in man. J Clin Endocrinol Metab (1980) 1.01
Adrenoleukodystrophy and adrenomyeloneuropathy associated with partial adrenal insufficiency in three generations of a kindred. Am J Med (1979) 0.99
Isolated deficiency of adrenocorticotropin (ACTH) and lipotropins (LPHs). J Clin Endocrinol Metab (1978) 0.98
Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem Biophys Res Commun (1987) 0.96
Concentrations of epidermal growth factor, nerve growth factor, and submandibular gland renin in male and female mouse tissue and fluids. Endocrinology (1979) 0.96
Preliminary characterization of the pituitary melanocyte stimulating hormones of several vertebrate species. Endocrinology (1972) 0.95
Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab (1982) 0.94
Secretion of ACTH and -MSH by an adrenal medullary paraganglioma. J Clin Endocrinol Metab (1972) 0.94
A case of ectopic ACTH syndrome: diagnostic difficulties caused by intermittent hormone secretion. Acta Endocrinol (Copenh) (1982) 0.94
High molecular weight forms of human ACTH are glycoproteins. J Clin Endocrinol Metab (1977) 0.94
Immunocytochemical localization of epidermal growth factor in the developing human respiratory system and in acute and chronic lung disease in the neonate. Lab Invest (1989) 0.94
Roles of intracellular and extracellular calcium in the kinetic profile of adrenocorticotropin secretion by perifused rat anterior pituitary cells. I. Corticotropin-releasing factor stimulation. Endocrinology (1990) 0.92
Submaxillary gland epidermal growth factor: a sensitive index of biologic androgen activity. Endocrinology (1974) 0.91
Effect of mouse epidermal growth factor/urogastrone on the functional maturation of rat intestine. Endocrinology (1983) 0.90
Ectopic production of high molecular weight calcitonin and corticotropin by human small cell carcinoma cells in tissue culture: evidence for separate precursors. J Clin Endocrinol Metab (1978) 0.90
Ontogeny of neuroendocrine cells in human fetal lung. II. An immunohistochemical study. Lab Invest (1985) 0.89
The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions. Endocrinology (1975) 0.89
Nature of the increase in renal ornithine decarboxylase activity after cycloheximide administration in the rat. Proc Natl Acad Sci U S A (1975) 0.88
Experimental alteration of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. J Clin Endocrinol Metab (1967) 0.88
Cerebrospinal fluid and plasma beta-endorphin in combat veterans with post-traumatic stress disorder. Psychoneuroendocrinology (1997) 0.88
Individual differences in repressive-defensiveness predict basal salivary cortisol levels. J Pers Soc Psychol (1996) 0.88
Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest (1984) 0.88
Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. Am J Med (1988) 0.88
Epidermal growth factor in human milk: daily production and diurnal variation during early lactation in mothers delivering at term and at premature gestation. J Pediatr (1983) 0.87
Angiotensin stimulates both early and late steps in aldosterone biosynthesis in isolated bovine glomerulosa cells. J Steroid Biochem (1978) 0.87
A pituitary parasellar tumor with extracranial metastases and high, partially suppressible levels of adrenocorticotropin and related peptides. J Clin Endocrinol Metab (1983) 0.87
Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol Psychiatry (1997) 0.87
Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis. J Clin Invest (1981) 0.87
Glucocorticoid receptors in pituitary tumor cells. I. Cytosol receptors. J Biol Chem (1973) 0.87
Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab (1992) 0.87
Distinct classes of corticotropes mediate corticotropin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release. Endocrinology (1991) 0.87
Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man. J Clin Endocrinol Metab (1983) 0.87
Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis. J Clin Endocrinol Metab (1973) 0.87